B3GALNT1 Products

Antibodies
B3GALNT1 Antibody - BSA Free
B3GALNT1 Antibody - BSA Free
NBP2-92677
Species: Hu, Mu, Rt
Applications: WB
Host: Rabbit Polyclonal
Formulation Catalog # Availability Price  
B3GALNT1 Antibody
B3GALNT1 Antibody
NBP1-74240
Species: Rt
Applications: WB
Host: Rabbit Polyclonal
B3GALNT1 Antibody
B3GALNT1 Antibody
NBP1-59448
Species: Hu
Applications: WB
Host: Rabbit Polyclonal
Lysates
B3GALNT1 293T Cell Transient ...
B3GALNT1 293T Cell Transient Overe...
H00008706-T01
Species: Hu
Applications: WB
Proteins
Recombinant Human B3GALNT1 GS ...
Recombinant Human B3GALNT1 GST (N-...
H00008706-P01
Species: Hu
Applications: WB, ELISA, MA, AP

Description

B3GALNT1 is part of the beta3GalT family which is involved with diverse enzymatic functions. This gene also associated with human pigmentation.

Bioinformatics

Entrez Human
Uniprot Human
Human
Product By Gene ID 8706
Alternate Names
  • b3Gal-T3
  • Beta-1,3-galactosyltransferase 3
  • Beta-1,3-GalNAc-T1
  • Beta-1,3-GalTase 3
  • beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)
  • beta3GalT3
  • Beta3GalT3
  • Beta3Gal-T3
  • Beta-3-Gx-T3
  • beta-3-Gx-T3
  • brainiac1
  • EC 2.4.1.79
  • Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase
  • Gb4Cer
  • GLCT3
  • Globoside synthase
  • globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase
  • P antigen synthase
  • P blood group globoside
  • P
  • polypeptide 3 (Globosideblood group)
  • UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1
  • UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1(Globoside blood group)
  • UDP-GalNAc:betaGlcNAc beta-1,3-galactosaminyltransferase, polypeptide 1(Globoside blood group)
  • UDP-N-acetylgalactosamine:globotriaosylceramidebeta-1,3-N-acetylgalactosaminyltransferase

Bioinformatics Tool for B3GALNT1

Discover related pathways, diseases and genes to B3GALNT1. Need help? Read the Bioinformatics Tool Guide for instructions on using this tool.
 
Vizit™, under license from BioVista Inc.